Point-of-care ultrasound for preeclampsia after delivery
Part of Blood & lymphatic, Cancer, Immune system & allergy, Women’s health & pregnancy clinical trials.
This study tests whether using a bedside ultrasound after childbirth can help doctors decide on better treatments for high blood pressure caused by preeclampsia. It may help reduce hospital stays and prevent readmissions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must have been diagnosed with preeclampsia during pregnancy or within 24 hours after giving birth
- You gave birth at 20 weeks of pregnancy or later
- You must not have had chronic high blood pressure before pregnancy
- You must not have significant kidney problems or low potassium levels
- You must not be allergic to furosemide or sulfa drugs
- You must not be taking water pills for other health conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses lung ultrasound to see if women with severe preeclampsia have too much fluid in their lungs, which could help guide treatment. It may help decide who needs closer monitoring or faster delivery.
This study looks at whether certain blood tests can help doctors manage high blood pressure after delivery in people with severe preeclampsia. It compares the usual care with additional blood tests to see if they improve recovery and reduce complications.
This trial studies whether using specific blood-pressure medicines can help people with non-severe preeclampsia stay pregnant longer. It aims to improve outcomes by treating blood pressure early while monitoring you and the baby closely.
This study is looking at women who develop high blood pressure or preeclampsia during pregnancy. Researchers will collect information to better understand these conditions, which may help improve care for future patients.
This study collects samples from pregnant people with preeclampsia (a serious pregnancy blood-pressure condition) and from healthy pregnancy controls. Researchers will study tiny particles (“exosomes”) to see how they differ and whether these signals could help explain or improve care for preeclampsia.
This trial tests a new medicine, CBP-4888, for pregnant women hospitalized with preeclampsia starting after 20 weeks. The goal is to see if it's safe and how it works for you and your baby, who will be followed for up to 24 months after birth.
Hear when a new Preeclampsia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.